Aklavine
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Explore a selection of our essential drug information below, or:
Identification
- Generic Name
- Aklavine
- DrugBank Accession Number
- DB19070
- Background
Aklavine is under investigation in clinical trial NCT03026842 (Decitabine Versus Conventional Chemotherapy for Maintenance Therapy of Acute Myeloid Leukemia With T(8;21)).
- Type
- Small Molecule
- Groups
- Investigational
- Structure
- Weight
- Average: 569.607
Monoisotopic: 569.226096331 - Chemical Formula
- C30H35NO10
- Synonyms
- 1-naphthacenecarboxylic acid, 2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-((2,3,6-trideoxy-3-(dimethylamino)-.alpha.-l-lyxo-hexopyranosyl)oxy)-, methyl ester, (1r,2r,4s)-
- Aclacinomycin
- Aclacinomycin t
- External IDs
- MA-144T1
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- T87WN25BNW
- CAS number
- 66676-88-8
- InChI Key
- LJZPVWKMAYDYAS-QKKPTTNWSA-N
- InChI
- InChI=1S/C30H35NO10/c1-6-30(38)12-19(41-20-11-17(31(3)4)25(33)13(2)40-20)22-15(24(30)29(37)39-5)10-16-23(28(22)36)27(35)21-14(26(16)34)8-7-9-18(21)32/h7-10,13,17,19-20,24-25,32-33,36,38H,6,11-12H2,1-5H3/t13-,17-,19-,20-,24-,25+,30-/m0/s1
- IUPAC Name
- SMILES
- [H][C@@]1(C[C@@H]([C@H](O)[C@H](C)O1)N(C)C)O[C@H]1C[C@](O)(CC)[C@H](C(=O)OC)C2=CC3=C(C(O)=C12)C(=O)C1=C(O)C=CC=C1C3=O
References
- General References
- Not Available
- External Links
- KEGG Compound
- C18634
- ChemSpider
- 131997
- ChEBI
- 74351
- ChEMBL
- CHEMBL3040622
- ZINC
- ZINC000003977735
- PDBe Ligand
- 3VL
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data4 Active Not Recruiting Prevention Acute Myeloid Leukemia 1 somestatus stop reason just information to hide 3 Recruiting Treatment Relapsed or Refractory Acute Myeloid Leukemia (AML) 1 somestatus stop reason just information to hide 2 Completed Treatment Acute Myeloid Leukemia 1 somestatus stop reason just information to hide 2 Recruiting Treatment Acute Myeloid Leukemia 1 somestatus stop reason just information to hide 2 Recruiting Treatment Refractory/Relapse Acute Myeloid Leukemia 1 somestatus stop reason just information to hide
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at July 03, 2024 14:34 / Updated at July 04, 2024 03:36